Over three million on new HIV drug dolutegravir, but co...

switching from old second-line regimens to dolutegravir-based regimensConcerns around drug to drug interactions with dolutegravir

Related Keywords

South Africa ,Brazil ,Botswana ,Brazilian ,Francois Venter ,Josephine Otchere Darko ,Foster Mohale ,National Department Of Health ,National Department Of Health Knowledge Hub ,Clinicians Society Sahcs ,World Health Organization ,University Of The Witwatersrand ,National Department ,Professor Francois Venter ,Southern African ,Knowledge Hub ,